Tag Archives: Merck

Supreme Court rebuffs appeals from Merck, Gilead in 2 high-profile drug battles

Monday was a good-news-bad-news day for Gilead Sciences at the U.S. Supreme Court, with the justices handing down multiple decisions about which appeals they would take up as they headed back to work after the holiday break. SCOTUS refused to hear Gilead’s appeal in a whistleblower case alleging it lied to the FDA about unapproved… Read More »

Pfizer, Merck KGaA's Bavencio takes a hit with second ovarian cancer failure

Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »

Solicitor general to back Merck at Supreme Court in Fosamax pre-emption case

Shortly after the U.S. Supreme Court agreed in June to hear Merck & Co.’s appeal in the years-long Fosamax liability litigation, acting Solicitor General Jefferey Wall asked for permission to present oral arguments. It would be a plus for Merck, because Wall has been a major voice on the hotly debated issue of pre-emption, which revolves around the question… Read More »